Atomoxetin Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Atomoxetin Hydrochloride
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Atomoxetin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 17 USDMF, 10 CEP/COS, 6 JDMF, 13 EU WC, 16 KDMF, 18 NDC API, 23 Listed Suppliers, $ API Reference Price

40 API Suppliers
17 USDMF
10 CEP/COS
6 JDMF
13 EU WC
16 KDMF
18 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

359 FDF Dossiers, 77 FDA Orange Book, 99 Europe, 66 Canada, 14 Australia, 43 South Africa, 60 Listed Dossiers

359 FDF Dossiers
77 FDA Orange Book
99 Europe
66 Canada
14 Australia
43 South Africa
60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 18MG BASE, CAPSULE;ORAL - EQ 25MG BASE, CAPSULE;ORAL - EQ 40MG BASE, CAPSULE;ORAL - EQ 60MG BASE, CAPSULE;ORAL - EQ 80MG BASE

CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 10MG BASE
CAPSULE;ORAL - EQ 18MG BASE
CAPSULE;ORAL - EQ 25MG BASE
CAPSULE;ORAL - EQ 40MG BASE
CAPSULE;ORAL - EQ 60MG BASE
CAPSULE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 8 DKSH, 2 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Finar, 2 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Pluviaendo, 1 Qualicaps, 8 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Valens Pharmachem

4 SPI Pharma
8 DKSH
2 Faran Shimi Pharmaceutical
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 ACG Worldwide
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
6 BASF
1 Finar
2 Gangwal Chemicals
2 Ingredion Pharma Solutions
1 Kerry
3 Lonza Capsugel
2 Pluviaendo
1 Qualicaps
8 Roquette
2 Seppic
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Sigachi Industries
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 8 Empty Capsules, 7 Thickeners and Stabilizers, 7 Direct Compression, 6 Taste Masking, 4 Lubricants & Glidants, 4 Film Formers & Plasticizers, 4 Granulation, 4 Topical, 3 Chewable & Orodispersible Aids, 3 Emulsifying Agents, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Coloring Agents, 2 Controlled & Modified Release, 2 Solubilizers, 1 Parenteral, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

17 Fillers, Diluents & Binders
9 Coating Systems & Additives
8 Empty Capsules
7 Thickeners and Stabilizers
7 Direct Compression
6 Taste Masking
4 Lubricants & Glidants
4 Film Formers & Plasticizers
4 Granulation
4 Topical
3 Chewable & Orodispersible Aids
3 Emulsifying Agents
3 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
3 Coloring Agents
2 Controlled & Modified Release
2 Solubilizers
1 Parenteral
1 API Stability Enhancers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

17 NEWS #PharmaBuzz

17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 49 Finished Drug Prices, 6 Annual Reports

2 US Medicaid Prescriptions
49 Finished Drug Prices
6 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers

7 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 5 USP, 14 Others

4 EDQM
5 USP
14 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 826 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Gowling Lafleur Henderson LLP

filter Patent Reset all filters

7 All

01 72209735

filter Product Reset all filters

7 All

01 7Atomoxetine Hydrochloride

filter Dosage Reset all filters

7 All

01 2Capsule

02 5Oral (capsules)

filter Exp Date Reset all filters

7 All

01 72016-01-04

Product Main Page

01

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 80mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 100mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 10 mg capsules

Dosage Form : Oral (capsules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 18 mg capsules

Dosage Form : Oral (capsules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 25 mg capsules

Dosage Form : Oral (capsules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 40 mg capsules

Dosage Form : Oral (capsules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gowling Lafleur Henderson LLP

Atomoxetin Hydrochloride

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Atomoxetin Hydrochloride

Brand Name : STRATTERA

Patent Number : 2209735

Filing Date : 1996-01-04

Strength per Unit : 60 mg capsules

Dosage Form : Oral (capsules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-01-04

Date Granted : 2002-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!